Breast Cancer Clinical Trial

Adherence Rate of Monthly Bubble Package Among Patients Prescribed Adjuvant Endocrine Therapy in Breast Cancer Survivors

Summary

This study aims to establish the feasibility of using a monthly bubble package to improve compliance rates among women prescribed adjuvant endocrine therapy.

View Full Description

Full Description

This study uses Bubble packaging to provide a cost effective way to improve compliance and help direct further interventions to ensure adherence in women on anti-estrogen therapy for breast cancer.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

18 years of age or older
Estrogen receptor positive (> 1% estrogen expression) by immunohistochemistry
Invasive breast cancer (stage I, II, III) or DCIS considered for adjuvant endocrine therapy

Exclusion Criteria:

Patients with metastatic disease (stage IV)
Patients less than 18 years of age
Prisoners
Patients are unable to fill prescriptions at the BCC pharmacy due to insurance limitations or personal preference

Study is for people with:

Breast Cancer

Estimated Enrollment:

87

Study ID:

NCT01694225

Recruitment Status:

Completed

Sponsor:

University of Louisville

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

James Graham Brown Cancer Center-University of Louisville
Louisville Kentucky, 40202, United States

How clear is this clinincal trial information?

Study is for people with:

Breast Cancer

Estimated Enrollment:

87

Study ID:

NCT01694225

Recruitment Status:

Completed

Sponsor:


University of Louisville

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider